TLR4 and necrotizing enterocolitis: This review outlines lactoferrin, oligosaccharides, exosomes in breast milk, stem cells and stem cells derived-exosomes, TLR4-targeted agents, and FMT, have demonstrated promising therapeutic effects and clinical application potential for the NEC therapy.